Royal Bank of Canada »

Trisalus Life Sciences shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0k 351 5.70
2025-06-30 $0 953 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Trisalus Life Sciences

Nantahala Capital Management
AWM Investment Company
Vanguard Group
Gilder, Gagnon, Howe & Co
BlackRock
Wealthcare Advisory Partners
Alyeska Investment Group
Geode Capital Management
State Street Corporation
Northern Trust
Goldman Sachs Group
CI Private Wealth
Squarepoint Ops
CWA Asset Management
Bridgeway Capital Management

View all funds holding Trisalus Life Sciences